EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Competitive performance as a discriminator of doping status in elite athletes

James G Hopker iD, Jim E Griffin iD, Laurentiu C Hinoveanu, Jonas Saugy, Raphael Faiss iD

Drug Testing and Analysis · 2024

DOI: 10.1002/dta.3563 ↗

At a glance

Journal article in Drug Testing and Analysis, 2024. Written by James G Hopker and 4 co-authors. Institution: School of Sport & Exercise Sciences, University of Kent, Canterbury, Kent, UK. Major MEDLINE topics: Doping in Sports, Athletes, Athletic Performance. Cited 9 times so far (Crossref); 21 references. The full text is freely available (open access, CC BY 4.0). Funded by: World Anti-Doping Agency.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

As the aim of any doping regime is to improve sporting performance, it has been suggested that analysis of athlete competitive results might be informative in identifying those at greater risk of doping. This research study aimed to investigate the utility of a statistical performance model to discriminate between athletes who have a previous anti‐doping rule violation (ADRV) and those who do not. We analysed performances of male and female 100 and 800 m runners obtained from the World Athletics database using a Bayesian spline model. Measures of unusual improvement in performance were quantified by comparing the yearly change in athlete's performance (delta excess performance) to quantiles of performance in their age‐matched peers from the database population. The discriminative ability of these measures was investigated using the area under the ROC curve (AUC) with the 55%, 75% and 90% quantiles of the population performance. The highest AUC values across age were identified for the model with a 75% quantile (AUC = 0.78–0.80). The results of this study demonstrate that delta excess performance was able to discriminate between athletes with and without ADRVs and therefore could be used to assist in the risk stratification of athletes for anti‐doping purposes.

Subjects

MeSH terms (MEDLINE)

Doping in SportsAthletesAthletic PerformanceHumansMaleFemaleAdultYoung AdultBayes TheoremRunningSubstance Abuse DetectionAdolescentROC Curve

Author keywords

Bayesianbiological passportdata analyticsmodellingrisk stratificationsportstarget testing

Authors and institutions

  • School of Sport & Exercise Sciences, University of Kent, Canterbury, Kent, UK.
  • Department of Statistical Science, University College London, London, UK.
  • Research & Expertise in Antidoping Sciences, University of Lausanne, Lausanne, Switzerland.

ORCID profiles: James G Hopker, Jim E Griffin, Raphael Faiss

Funding

  • World Anti-Doping Agency

Cite

APA

Hopker, J. G., Griffin, J. E., Hinoveanu, L. C., Saugy, J., & Faiss, R. (2024). Competitive performance as a discriminator of doping status in elite athletes. Drug Testing and Analysis. https://doi.org/10.1002/dta.3563

Vancouver

Hopker JG, Griffin JE, Hinoveanu LC, Saugy J, Faiss R. Competitive performance as a discriminator of doping status in elite athletes. Drug Testing and Analysis. 2024. doi:10.1002/dta.3563

BibTeX
@article{Hopker2024,
  author = {Hopker, James G and Griffin, Jim E and Hinoveanu, Laurentiu C and Saugy, Jonas and Faiss, Raphael},
  title = {Competitive performance as a discriminator of doping status in elite athletes},
  journal = {Drug Testing and Analysis},
  year = {2024},
  doi = {10.1002/dta.3563}
}
Start for free →